EQRX — EQRx Balance Sheet
0.000.00%
HealthcareSpeculativeMid Cap
- $1.14bn
- -$71.09m
Annual balance sheet for EQRx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 18.5 | 490 | 1,679 | 1,399 |
| Prepaid Expenses | ||||
| Total Current Assets | 18.5 | 492 | 1,706 | 1,428 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 0.078 | 7.58 | 4.66 | 6.43 |
| Long Term Investments | ||||
| Other Long Term Assets | ||||
| Total Assets | 19.5 | 501 | 1,729 | 1,455 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Current Liabilities | 28 | 14.2 | 39.6 | 51.9 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 28 | 18.4 | 215 | 66.2 |
| Redeemable Preferred Stock | ||||
| Non Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | -8.51 | 482 | 1,515 | 1,389 |
| Total Liabilities & Shareholders' Equity | 19.5 | 501 | 1,729 | 1,455 |
| Total Common Shares Outstanding |